Literature DB >> 25561807

Increased expression of tumor necrosis factor-α is associated with advanced colorectal cancer stages.

Omar A Al Obeed1, Khayal A Alkhayal1, Abdulmalik Al Sheikh1, Ahmad M Zubaidi1, Mansoor-Ali Vaali-Mohammed1, Robin Boushey1, James H Mckerrow1, Maha-Hamadien Abdulla1.   

Abstract

AIM: To detect the expression of tumor necrosis factor-α (TNF-α) in colorectal cancer (CRC) cells among Saudi patients, and correlate its expression with clinical stages of cancer.
METHODS: Archival tissue specimens were collected from 30 patients with CRC who had undergone surgical intervention at King Khalid University Hospital. Patient demographic information, including age and gender, tumor sites, and histological type of CRC, was recorded. To measure TNF-α mRNA expression in CRC, total RNA was extracted from tumor formalin-fixed, paraffin-embedded, and adjacent normal tissues. Reverse transcription and reverse transcription polymerase chain reaction were performed. Colorectal tissue microarrays were constructed to investigate the protein expression of TNF-α by immunohistochemistry.
RESULTS: The relative expression of TNF-α mRNA in colorectal cancer was significantly higher than that seen in adjacent normal colorectal tissue. High TNF-α gene expression was associated with Stage III and IV neoplasms when compared with earlier tumor stages (P = 0.004). Eighty-three percent of patients (25/30) showed strong TNF-α positive staining, while only 10% (n = 3/30) of patients showed weak staining, and 7% (n = 2/30) were negative. We showed the presence of elevated TNF-α gene expression in cancer cells, which strongly correlated with advanced stages of tumor.
CONCLUSION: High levels of TNF-α expression could be an independent diagnostic indicator of colorectal cancer, and targeting TNF-α might be a promising prognostic tool by assessment of the clinical stages of CRC.

Entities:  

Keywords:  Colorectal cancer; Immunohistochemistry; Real time polymerase chain reaction; Tumor necrosis factor-α; mRNA

Mesh:

Substances:

Year:  2014        PMID: 25561807      PMCID: PMC4277977          DOI: 10.3748/wjg.v20.i48.18390

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Where have all the T cells gone? Mechanisms of immune evasion by tumors.

Authors:  J Finke; S Ferrone; A Frey; A Mufson; A Ochoa
Journal:  Immunol Today       Date:  1999-04

2.  Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas.

Authors:  K Warzocha; P Ribeiro; N Renard; J Bienvenu; C Charlot; B Coiffier; G Salles
Journal:  Cancer Immunol Immunother       Date:  2000-11       Impact factor: 6.968

3.  Cancer: an inflammatory link.

Authors:  Fran Balkwill; Lisa M Coussens
Journal:  Nature       Date:  2004-09-23       Impact factor: 49.962

4.  Expression of interleukin-1beta and tumour necrosis factor-alpha in plasma cells from patients with multiple myeloma.

Authors:  H I Sati; M Greaves; J F Apperley; R G Russell; P I Croucher
Journal:  Br J Haematol       Date:  1999-02       Impact factor: 6.998

5.  Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer.

Authors:  Martin Grimm; Mia Kim; Andreas Rosenwald; Burkhard H A von Raden; Burkhard von Rahden; Igor Tsaur; Eva Meier; Uwe Heemann; Christoph-Thomas Germer; Martin Gasser; Ana Maria Waaga-Gasser
Journal:  Eur J Cancer       Date:  2010-06-25       Impact factor: 9.162

Review 6.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

7.  Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.

Authors:  Karin Zins; Dietmar Abraham; Mouldy Sioud; Seyedhossein Aharinejad
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

Review 8.  The tumor microenvironment: a critical determinant of neoplastic evolution.

Authors:  Léon C L T van Kempen; Dirk J Ruiter; Goos N P van Muijen; Lisa M Coussens
Journal:  Eur J Cell Biol       Date:  2003-11       Impact factor: 4.492

9.  First national survival data for colorectal cancer among Saudis between 1994 and 2004: what's next?

Authors:  Mahmoud S Al-Ahwal; Yasmin H Shafik; Hazem M Al-Ahwal
Journal:  BMC Public Health       Date:  2013-01-25       Impact factor: 3.295

10.  The pattern of cytokine gene expression in human colorectal carcinoma.

Authors:  Anna Csiszár; Tamás Szentes; Bea Haraszti; Annamária Balázs; Gyôzô G Petrányi; Eva Pócsik
Journal:  Pathol Oncol Res       Date:  2004-06-09       Impact factor: 2.874

View more
  38 in total

1.  Comparative Study between Curcumin and Nanocurcumin Loaded PLGA on Colon Carcinogenesis Induced Mice.

Authors:  Farida E Elbassiouni; Wafaa M El-Kholy; El-Sayed M Elhabibi; Sarah Albogami; Eman Fayad
Journal:  Nanomaterials (Basel)       Date:  2022-01-20       Impact factor: 5.076

2.  Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profiles.

Authors:  Kelsey E Huntington; Anna Louie; Lanlan Zhou; Attila A Seyhan; Aaron Wp Maxwell; Wafik S El-Deiry
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

Review 3.  Tumour burden and efficacy of immune-checkpoint inhibitors.

Authors:  Filippo G Dall'Olio; Aurélien Marabelle; Caroline Caramella; Camilo Garcia; Mihaela Aldea; Nathalie Chaput; Caroline Robert; Benjamin Besse
Journal:  Nat Rev Clin Oncol       Date:  2021-10-12       Impact factor: 66.675

4.  In-silico and in-vitro studies on the efficacy of mangiferin against colorectal cancer.

Authors:  Rohini Samadarsi; Linus Augustin; Chandan Kumar; Debjani Dutta
Journal:  BMC Chem       Date:  2022-06-07

5.  DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice.

Authors:  Yue Guo; Renyi Wu; John M Gaspar; Davit Sargsyan; Zheng-Yuan Su; Chengyue Zhang; Linbo Gao; David Cheng; Wenji Li; Chao Wang; Ran Yin; Mingzhu Fang; Michael P Verzi; Ronald P Hart; Ah-Ng Kong
Journal:  Carcinogenesis       Date:  2018-05-03       Impact factor: 4.944

6.  Probiotic Pediococcus acidilactici strain from tomato pickle displays anti-cancer activity and alleviates gut inflammation in-vitro.

Authors:  Anuradha Barigela; Bhima Bhukya
Journal:  3 Biotech       Date:  2021-01-03       Impact factor: 2.406

7.  Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.

Authors:  Shu Yang; Wenshuai Li; Haimei Sun; Bo Wu; Fengqing Ji; Tingyi Sun; Huanhuan Chang; Ping Shen; Yaxi Wang; Deshan Zhou
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

Review 8.  Cytokine-Induced Modulation of Colorectal Cancer.

Authors:  Lukas F Mager; Marie-Hélène Wasmer; Tilman T Rau; Philippe Krebs
Journal:  Front Oncol       Date:  2016-04-19       Impact factor: 6.244

9.  Polymorphisms of tumor necrosis factor alpha in Middle Eastern population with colorectal cancer.

Authors:  Maha-Abdulla Hamadien; Zahid Khan; Mansoor-Ali Vaali-Mohammed; Ahmad Zubaidi; Khayal Al-Khayal; James McKerrow; Omar Al-Obeed
Journal:  Tumour Biol       Date:  2015-11-16

Review 10.  TH17 Cell and Epithelial Cell Crosstalk during Inflammatory Bowel Disease and Carcinogenesis.

Authors:  Jan Kempski; Leonie Brockmann; Nicola Gagliani; Samuel Huber
Journal:  Front Immunol       Date:  2017-10-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.